Abstract
These days we all suffer from information overload. To overcome this problem, the Stem Cell News service focuses specifically on stem cell research, delivering the information you need in a timely, flexible and convenient format.
Much is expected from stem cell research. Controversial ethical issues, such as harvesting and use of stem cells, are balanced by very real progress in their research and clinical application in certain cancers, blood disorders and tissue engineering. However, conditions as diverse as Parkinson' s disease and diabetes are also expected to benefit.
How might stem cell research help or hinder the healthcare industry? What are the commercial opportunities and risk? Which organisations are driving development?
For pharmaceutical/medical company executives, researchers and commercial managers, stem cells are taking a central role in the industry' s medium to long-term plans. Staying in touch with the latest research and development findings, however, is another matter. That is why this new, daily-updated online information service is essential.
Stem Cell News provides:
- The full text of the latest news reported on stem cells, and their research and clinical applications
- An easy-to-use interface that immediately takes you to the most recently updated information
- An extensive archive of articles which makes the service a valuable tracking and research tool
- A fast and effective search facility allowing you to identify information relevant to your needs
- Daily or weekly email alerts which will ensure you know when new information is added
- An RSS feed facility
Every day, Espicom' s researchers and editors
- Track the organisations that are undertaking novel research and shaping the industry
- Report the latest developments in current and up coming stem cell applications
- Monitor results from major conferences and meetings
